Figure 3From: Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugsDistribution of NtAI, LST and HRD-LOH signature scores by MSI status in colon, gastric and endometrial cancer. Tumors are grouped by MSI (microsatellite instable) or MSS (microsatellite stable). Horizontal black lines indicate 25th, 50th and 75th percentiles.Back to article page